Final height and pubertal growth in Japanese patients with congenital hypothyroidism detected by neonatal screening

被引:17
作者
Adachi, M [1 ]
Asakura, Y [1 ]
Tachibana, K [1 ]
机构
[1] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Minami Ku, Yokohama, Kanagawa 2328555, Japan
关键词
auxology; congenital hypothyroidism; final height; menarche; neonatal screening; pubertal pattern;
D O I
10.1080/08035250310002759
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
To investigate the final adult heights and pubertal growth patterns in Japanese patients with congenital hypothyroidism (CH) detected by neonatal screening. Methods: A retrospective chart review was conducted of female patients > 15 y of age (n = 18) and male patients > 18 y of age (n = 9), who were detected by neonatal screening and kept on continuous thyroid hormone replacement therapy. Final height standard deviation scores (FHSDS) and target height standard deviation scores (THSDS) were determined. Parameters characterizing the pubertal growth process (such as age at onset of pubertal growth spurt and age at peak pubertal growth) were obtained from each patient's growth rate chart. Menarchial age was determined in each female patient by reviewing the medical record. The impact on FHSDS of the etiology of CH, the severity of CH, the time of initiation of therapy and the adequacy of treatment during the first year of life was assessed. Results: All patients had received initial thyroid hormone treatment no later than 50 d of age, and had reached their final height. The mean FHSDS for female and male patients were +0.17 +/- 0.99 and -0.03 +/- 0.99, respectively. The mean FHSDS-THSDS for female and male patients was +0.09 +/- 0.77 and -0.19 +/- 0.53, respectively. No difference was seen in pubertal growth parameters for either gender compared with that of the reference population, except for a greater peak height velocity and pubertal height gain in male patients. The mean menarchial age was identical to that of the reference population. No significant relationship was found between the FHSDS and any of the factors investigated. Conclusion: The adult height of patients with CH detected by neonatal screening was equivalent to that of the reference population and their target height. As long as early intervention and satisfactory management are ensured, severe CH does not appear to reduce final adult height.
引用
收藏
页码:698 / 703
页数:6
相关论文
共 21 条
[1]  
[Anonymous], 1985, J Pediatr, V107, P915
[2]   GROWTH IN CHILDREN WITH CONGENITAL HYPOTHYROIDISM DETECTED BY NEONATAL SCREENING [J].
ARONSON, R ;
EHRLICH, RM ;
BAILEY, JD ;
ROVET, JF .
JOURNAL OF PEDIATRICS, 1990, 116 (01) :33-37
[3]   Adult height in congenital hypothyroidism: Prognostic factors and the importance of compliance with treatment [J].
Bain, P ;
Toublanc, JE .
HORMONE RESEARCH, 2002, 58 (03) :136-142
[4]   Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism [J].
Bongers-Schokking, JJ ;
Koot, HM ;
Wiersma, D ;
Verkerk, PH ;
Keizer-Schrama, SMPFD .
JOURNAL OF PEDIATRICS, 2000, 136 (03) :292-297
[5]  
BUCHER H, 1985, HELV PAEDIATR ACTA, V40, P305
[6]  
CHIESA A, 1994, J PEDIATR ENDOCRINOL, V7, P211
[7]   EVOLUTION OF HEIGHT AND BONE-AGE IN PRIMARY CONGENITAL HYPOTHYROIDISM [J].
DEFRIAS, EC ;
RUIBAL, JL ;
REVERTE, F ;
BUENO, G .
CLINICAL PEDIATRICS, 1993, 32 (07) :426-432
[8]   Prepubertal and pubertal growth, timing and duration of puberty and attained adult height in patients with congenital hypothyroidism (CH) detected by the neonatal screening programme for CH - a longitudinal study [J].
Dickerman, Z ;
De Vries, L .
CLINICAL ENDOCRINOLOGY, 1997, 47 (06) :649-654
[9]   GROWTH IN EARLY TREATED CONGENITAL HYPOTHYROIDISM [J].
GRANT, DB .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 70 (06) :464-468
[10]   Treatment variables as predictors of intellectual outcome in children with congenital hypothyroidism [J].
Heyerdahl, S .
EUROPEAN JOURNAL OF PEDIATRICS, 1996, 155 (05) :357-361